| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 41.38B | 47.02B | 44.65B | 46.38B | 37.62B | 33.03B |
| Gross Profit | 2.83B | 4.39B | 2.54B | 4.26B | 1.87B | 1.56B |
| EBITDA | 2.42B | 3.98B | 2.23B | 4.00B | 1.60B | 1.28B |
| Net Income | 1.20B | 2.30B | 1.02B | 2.26B | 737.00M | 143.00M |
Balance Sheet | ||||||
| Total Assets | 42.34B | 47.14B | 42.49B | 43.82B | 40.20B | 36.81B |
| Cash, Cash Equivalents and Short-Term Investments | 11.63B | 12.78B | 4.70B | 14.80B | 9.31B | 16.28B |
| Total Debt | 4.19B | 2.63B | 5.68B | 8.96B | 9.41B | 9.71B |
| Total Liabilities | 31.15B | 33.63B | 31.63B | 34.07B | 32.77B | 30.01B |
| Stockholders Equity | 11.18B | 13.51B | 10.86B | 9.74B | 7.43B | 6.79B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 11.22B | -6.58B | 5.96B | -7.88B | 9.28B |
| Operating Cash Flow | 0.00 | 12.46B | -5.38B | 6.75B | -6.38B | 10.78B |
| Investing Cash Flow | 0.00 | -3.25B | -1.20B | -824.00M | -249.00M | -1.68B |
| Financing Cash Flow | 0.00 | -3.12B | -3.44B | -528.00M | -359.00M | -278.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | ¥239.27B | 11.89 | 16.64% | 1.36% | -0.12% | -17.83% | |
64 Neutral | ¥15.68B | 7.06 | ― | 0.27% | 5.30% | 126.07% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | ¥17.83B | 9.98 | ― | 5.14% | -1.12% | 22.15% | |
59 Neutral | ¥417.74B | 11.17 | 13.69% | 0.60% | 12.09% | -1.60% | |
59 Neutral | ¥9.13B | 6.33 | ― | 2.71% | 7.29% | 20.12% | |
52 Neutral | ¥3.23B | 17.83 | ― | 0.67% | 6.22% | 385.27% |